Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective crossover MRI contrast study in IPMT: Omniscan vs Dotarem
2010-023345-30Phase 4Completed
- Sponsor
- AULSS n. 2 Marca Trevigiana
- Start
- Nov 2010
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of gadodiamide and gadoterate meglumine in intraductal papillary mucinous neoplasm (IPMN) (2 arms), sponsored by AULSS n. 2 Marca Trevigiana. Started Nov 2010; status: completed.
02
Drugs
gadodiamidegadoterate meglumine
03
Conditions
intraductal papillary mucinous neoplasm (IPMN)
Beyond the preview
Go deeper on 2010-023345-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023345-30.